Strativa announced that the FDA has approved Nascobal (cyanocobalamin) Nasal Spray in a single-use device for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement. It is also indicated as a supplement for other vitamin B12 deficiencies (eg, dietary deficiency, malabsoprtion).
Nascobal is a vitamin B12 supplement that delivers 500mcg cyanocobalamin per spray. No priming is required with the new single-use, once-weekly disposable device, delivering a precise dose. This product will replace the current multi-use glass bottle with actuator pump.
Nascobal Nasal Spray in a single-use device is available in a 3mL bottle (containing 1.3mL solution) as a 4-count carton for a one month supply. It will be available in September 2014.
For more information call or visit Nascobal.com.